BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17277020)

  • 1. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
    Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
    Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
    Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
    Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
    Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
    Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of infarct size by short-term pretreatment with atorvastatin.
    Birnbaum Y; Ashitkov T; Uretsky BF; Ballinger S; Motamedi M
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):25-30. PubMed ID: 12843684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
    Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
    Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
    Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
    Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
    Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
    Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
    Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin.
    Ye Y; Long B; Qian J; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):391-9. PubMed ID: 20640495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway.
    Bell RM; Yellon DM
    J Am Coll Cardiol; 2003 Feb; 41(3):508-15. PubMed ID: 12575984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats.
    Sun YM; Tian Y; Li X; Liu YY; Wang LF; Li J; Li ZQ; Pan W
    Biochem Biophys Res Commun; 2009 May; 382(2):336-40. PubMed ID: 19275881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.
    Bulhak A; Roy J; Hedin U; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3158-63. PubMed ID: 17322412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
    Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
    Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect.
    Nanhwan MK; Ling S; Kodakandla M; Nylander S; Ye Y; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2078-85. PubMed ID: 25012137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat.
    Birnbaum Y; Lin Y; Ye Y; Merla R; Perez-Polo JR; Uretsky BF
    J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):72-9. PubMed ID: 18287593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.
    Gross ER; Hsu AK; Gross GJ
    Anesth Analg; 2009 Nov; 109(5):1395-402. PubMed ID: 19843777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acute and chronic atorvastatin on cardioprotection of ischemic postconditioning in isolated rat hearts.
    Fan Y; Yang S; Cao Y; Huang Y
    Cardiovasc Ther; 2013 Aug; 31(4):187-92. PubMed ID: 22954178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.